Biopharma's Tech Adoption Challenges
Life sciences-focused cloud startup Benchling has seen its business soar over the last few years, amid a renewed interest in biotech among investors. Benchling CEO Sajith Wickramasekara joins Caroline Hyde and Ed Ludlow to discuss the state of the global biopharma industry and its adoption of technology. He speaks on "Bloomberg... #press